SLC25A3 and heart disorder: Multiple studies clearly connect SLC25A3 to phosphate transport, and mutations in SLC25A3 lead to skeletal muscle myopathy and heart disease in humans (Boulet et al., 2018; Seifert et al., 2016; Bhoj et al., 2015; Kwong et al., 2014; Mayr et al., 2011; Mayr et al., 2007) and cardiac hypertrophy in mice (Kwong et al., 2014).